The aim of the project is to power the novel patient-centered program to improve the triage and the management of population with cardiovascular risk condition
BROSSARD, QUEBEC — (Marketwired) — 10/24/17 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today a positive conclusion to a pilot project by signing a turnkey one-year screening contract in North Africa.So far, DIAGNOS– healthcare services have been rendered in 16 countries worldwide. During the
BROSSARD, QUEBEC — (Marketwired) — 10/23/17 — DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces the closing of a second tranche of 2 units (each a "Unit"), for gross cash receipts of $100,000, as part of a private placement ("Private Placement") initially announced on October 16, 2017. The aggregate cash receipts f
BROSSARD, QUEBEC — (Marketwired) — 10/17/17 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the addition of a new partner to cover Cambodia, Garuda Health Services. Cambodia is the 16th country in the world where we will be able screen patients.Garuda Health Services (GHS) first customer will
BROSSARD, QUEBEC — (Marketwired) — 10/16/17 — DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces closing of a private placement ("Private Placement"), as of October 13, 2017, of 18 units (each a "Unit") for gross cash proceeds of $900,000. Each Unit consists of:At the sole option of the holder of the Notes, the princ
BROSSARD, QUEBEC — (Marketwired) — 09/26/17 — DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, is pleased to announce that the Corporation–s common shares traded on the OTC Markets Group Inc.–s OTCQB Venture Market in the United States, under the symbol "DGNOF", are Depository Trust Company ("DTC") eligible, effective Sept
Cardiovascular Artery Disease (CAD) prevention score development six to twelve months ahead of schedule; commercial launch in first half of 2018
BROSSARD, QUEBEC — (Marketwired) — 08/28/17 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the refiling of the March 31, 2017 annual filings comprised of the restated March 31, 2017 annual financial statements and the restated annual Management Discussion and Analysis as well as the restated
BROSSARD, QUEBEC — (Marketwired) — 08/22/17 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the implementation of DIAGNOS CARA (Computer Assisted Retina Analysis) telemedicine platform at Al Kahhal Medical Complex clinic. With our Saudi Arabia business partner, Al Kanhoor Medical Co, we will
BROSSARD, QUEBEC — (Marketwired) — 08/14/17 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today results from the votes at the annual general meeting of shareholders ("AGM") held on July 21, 2017, the appointments of Mr. Georges Hebert as Chairman of the board of directors and Dr. Hadi Ch